These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35977518)

  • 1. Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer.
    Gupta P; Strange K; Telange R; Guo A; Hatch H; Sobh A; Elie J; Carter AM; Totenhagen J; Tan C; Sonawane YA; Neuzil J; Natarajan A; Ovens AJ; Oakhill JS; Wiederhold T; Pacak K; Ghayee HK; Meijer L; Reddy S; Bibb JA
    Cell Rep; 2022 Aug; 40(7):111218. PubMed ID: 35977518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK5 activator protein p25 preferentially binds and activates GSK3β.
    Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
    Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Cdk5 in neuroendocrine thyroid cancer.
    Pozo K; Castro-Rivera E; Tan C; Plattner F; Schwach G; Siegl V; Meyer D; Guo A; Gundara J; Mettlach G; Richer E; Guevara JA; Ning L; Gupta A; Hao G; Tsai LH; Sun X; Antich P; Sidhu S; Robinson BG; Chen H; Nwariaku FE; Pfragner R; Richardson JA; Bibb JA
    Cancer Cell; 2013 Oct; 24(4):499-511. PubMed ID: 24135281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
    Cole AR; Soutar MP; Rembutsu M; van Aalten L; Hastie CJ; McLauchlan H; Peggie M; Balastik M; Lu KP; Sutherland C
    J Biol Chem; 2008 Jun; 283(26):18227-37. PubMed ID: 18460467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
    Plattner F; Angelo M; Giese KP
    J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
    J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
    Hallows JL; Chen K; DePinho RA; Vincent I
    J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor activation induces tau phosphorylation via cdk5 and GSK3 signaling pathways.
    Lebel M; Patenaude C; Allyson J; Massicotte G; Cyr M
    Neuropharmacology; 2009 Sep; 57(4):392-402. PubMed ID: 19591849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpastatin, an endogenous calpain-inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25.
    Sato K; Minegishi S; Takano J; Plattner F; Saito T; Asada A; Kawahara H; Iwata N; Saido TC; Hisanaga S
    J Neurochem; 2011 May; 117(3):504-15. PubMed ID: 21338355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic distribution of CDK5 mRNA and p35 mRNA, and a glutamate-responsive increase of CDK5/p25 complex contribute to tau hyperphosphorylation.
    Tanaka T; Ohashi S; Takashima A; Kobayashi S
    Biochim Biophys Acta Gen Subj; 2022 Jul; 1866(7):130135. PubMed ID: 35358667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
    Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
    J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.
    Eggers JP; Grandgenett PM; Collisson EC; Lewallen ME; Tremayne J; Singh PK; Swanson BJ; Andersen JM; Caffrey TC; High RR; Ouellette M; Hollingsworth MA
    Clin Cancer Res; 2011 Oct; 17(19):6140-50. PubMed ID: 21825040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
    Crespo-Biel N; Canudas AM; Camins A; Pallàs M
    Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
    Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
    J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
    Ramos-Miguel A; García-Sevilla JA
    Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.